ArticleAmerican journal of preventive cardiology2025
Obesity-attributable risk of cardiovascular disease (CVD) in the United States: a Bayesian network analysis.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis.Circulation research · 2026Review
- Unraveling the Potential Role of Spexin in Exercise-Induced Improvement of Cardiometabolic Health in Obesity and Diabetes.Current obesity reports · 2026Review
- Sex Differences in the Impact of Obesity on Immunity.Immunological reviews · 2026Review
- Lowering barriers Not the bar: Redefining the role of American Journal of Preventive Cardiology in the next era.American journal of preventive cardiology · 2026Article
- Prevalence and Factors Associated with GLP-1 Receptor Agonist Use for Weight Management Among Overweight and Obese Adults in the Eastern Province of Saudi Arabia.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity and related complications present clinical and financial burdens for patients and health care systems. Quantification of the impact of obesity on cardiovascular disease (CVD) would aid in disease management. This study aimed to apply Bayesian networks to nationally representative data to analyze the relationship between obesity and CVD. Methods: Self-reported medical history, risk factor status, and physiological measurements were longitudinally adapted from the National Health and Nutrition Examination Survey (1999-2018). Respondents were required to have weight history and ≥1 CVD outcome, including myocardial infarction, stroke, heart failure, or overall CVD. The cohort was restricted to respondents ≥35 years to ensure recent weight measurements were sufficiently captured. Population attributable fractions were estimated via the traditional approach (assessing direct effects of exposures on outcomes) and Bayesian networks (assessing indirect effects of interdependent relationships) for each CVD outcome. Results: Obesity was reported in 31 %-32 % of respondents with any CVD outcome (n = 29,388-29,529). CVD outcomes attributed to obesity through the traditional approach were estimated to be <4 %. Using Bayesian networks, estimates of myocardial infarction, stroke, heart failure, and CVD cases attributable to obesity were 21 %, 16 %, 38 %, and 19 %, respectively. For all Bayesian networks, >80 % of the total effect of obesity was attributable to its effect on intermediate medical conditions. Conclusions: These data highlight obesity as a significant CVD risk factor. This work has provided valuable insight into the relationship between obesity and CVD-related outcomes, indicating a need for greater clinical attention to obesity to lessen the burden of downstream complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.